|
Written by Webmaster
Friday, 06 August 2010 17:21
|
|
| MédiMabs is proud to announce the licensing of Monoclonal antibody C9 against the A2 protein of Leishmania. This antibody reacts against the amastigotes specific protein A2 present in Leishmania donovani and Leishmania infantum. |
